The Tumor-Suppressing Activity of Angiostatin Protein Resides within Kringles 1 to 3
- 22 October 1999
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 264 (2), 469-477
- https://doi.org/10.1006/bbrc.1999.1486
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutantNature, 1994
- The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.Endocrinology, 1993
- Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activityThe Journal of cell biology, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of InfancyNew England Journal of Medicine, 1992
- The 16K Fragment of Prolactin Specifically Inhibits Basal or Fibroblast Growth Factor Stimulated Growth of Capillary Endothelial CellsEndocrinology, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon.Journal of Clinical Oncology, 1986
- Anti-AngiogenesisAnnals of Surgery, 1972
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971